Martin Vazquez - 11 Nov 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role: Chief Operating Officer
Signature: By: John L Brottem For: Martin Vazquez
Issuer symbol: OM
Transactions as of: 11 Nov 2022
Net transactions value: -$241,800
Form type: 4
Filing time: 14 Nov 2022, 18:59:42 UTC
Previous filing: 16 Aug 2022
Next filing: 17 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OM	Common Stock	Options Exercise	$19,400	+5,000	+10%	$3.88^*	54,550	11 Nov 2022	Direct	F1
transaction	OM	Common Stock	Sale	$100,000	-5,000	-9.2%	$20.00	49,550	11 Nov 2022	Direct	F2
transaction	OM	Common Stock	Options Exercise	$19,400	+5,000	+10%	$3.88^*	54,550	11 Nov 2022	Direct
transaction	OM	Common Stock	Sale	$100,000	-5,000	-9.2%	$20.00	49,550	11 Nov 2022	Direct	F2
transaction	OM	Common Stock	Options Exercise	$17,964	+4,630	+9.3%	$3.88^*	54,180	11 Nov 2022	Direct
transaction	OM	Common Stock	Sale	$92,600	-4,630	-8.5%	$20.00	49,550	11 Nov 2022	Direct	F2
transaction	OM	Common Stock	Options Exercise	$1,436	+370	+0.75%	$3.88^*	49,920	11 Nov 2022	Direct
transaction	OM	Common Stock	Sale	$7,400	-370	-0.74%	$20.00	49,550	11 Nov 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OM	Performance Options (right to buy)	Options Exercise	$0	-5,000	-5.1%	$0.000000	93,007	11 Nov 2022	Common Stock	5,000	$3.88	Direct	F3
transaction	OM	Performance Options (right to buy)	Options Exercise	$0	-5,000	-5.4%	$0.000000	88,007	11 Nov 2022	Common Stock	5,000	$3.88	Direct	F3
transaction	OM	Performance Options (right to buy)	Options Exercise	$0	-4,630	-5.3%	$0.000000	83,377	11 Nov 2022	Common Stock	4,630	$3.88	Direct	F3
transaction	OM	Performance Options (right to buy)	Options Exercise	$0	-370	-0.44%	$0.000000	83,007	11 Nov 2022	Common Stock	370	$3.88	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 573 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2022 to August 31, 2022. This transaction is exempt from Rule 16b-3(c).
F2	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.
F3	In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.